QUOMAK
0448.488.111 · rovalta.com · 22/09/2026
QUOMAK
Overview
What does QUOMAK do?
QUOMAK is a Public limited company incorporated in 1992. Its registered office is in Leuven. It employs on average 9,4 ETP workers (FTE).
3001 Leuven · FlandreSee on map
Joint committees (1)
- 220
Trend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||||
| Gross margin | 4,6 M € | -0.3% | 4,7 M € | +7.6% | 4,3 M € | +7.3% | 4 M € | +15.5% | 3,5 M € | +16.8% | 3 M € | +10.7% | 2,7 M € | +23.0% | 2,2 M € | +2.7% | 2,1 M € | -5.0% | 2,2 M € | +34.4% | 1,7 M € | +11.8% | 1,5 M € | +21.6% | 1,2 M € | +2.4% | 1,2 M € | +17.3% | 1 M € | +1.4% | 1 M € | +36.0% | 742,8 k € | -18.4% | 910,3 k € | +47.9% | 615,7 k € | +27.2% | 484 k € |
| EBITDA | 3,5 M € | -6.9% | 3,8 M € | +5.4% | 3,6 M € | +11.0% | 3,2 M € | +21.4% | 2,6 M € | +14.8% | 2,3 M € | +14.8% | 2 M € | +31.0% | 1,5 M € | +8.9% | 1,4 M € | -9.6% | 1,6 M € | +49.3% | 1 M € | +15.7% | 901,4 k € | +26.0% | 715,5 k € | -1.1% | 723,8 k € | +41.3% | 512,4 k € | -11.3% | 577,9 k € | +67.6% | 344,8 k € | -35.2% | 532 k € | +107% | 256,6 k € | +65.6% | 154,9 k € |
| Operating result | 3,4 M € | -6.0% | 3,7 M € | +5.5% | 3,5 M € | +11.8% | 3,1 M € | +20.3% | 2,6 M € | +14.8% | 2,2 M € | +14.6% | 2 M € | +32.1% | 1,5 M € | +9.7% | 1,3 M € | -9.3% | 1,5 M € | +66.1% | 895,4 k € | +16.6% | 767,9 k € | +31.1% | 585,7 k € | +2.5% | 571,3 k € | +51.9% | 376,1 k € | -16.7% | 451,6 k € | +72.3% | 262,1 k € | -38.4% | 425,8 k € | +125% | 189,5 k € | +115% | 88,3 k € |
| Net result | 2,6 M € | -4.0% | 2,7 M € | +5.4% | 2,6 M € | +12.0% | 2,3 M € | +20.3% | 1,9 M € | +15.0% | 1,7 M € | +21.9% | 1,4 M € | +31.3% | 1 M € | +18.3% | 883,8 k € | -10.7% | 990,3 k € | +61.9% | 611,8 k € | +18.7% | 515,5 k € | +30.4% | 395,3 k € | -1.1% | 399,8 k € | +60.7% | 248,8 k € | -16.7% | 298,8 k € | +75.6% | 170,1 k € | -32.8% | 253,2 k € | +135% | 107,9 k € | +154% | 42,5 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||||
| Equity | 5,3 M € | +55.1% | 3,4 M € | +27.5% | 2,7 M € | +59.4% | 1,7 M € | +199% | 559,2 k € | -51.8% | 1,2 M € | +0.3% | 1,2 M € | -0.6% | 1,2 M € | +0.5% | 1,2 M € | -4.6% | 1,2 M € | -51.9% | 2,5 M € | +22.4% | 2,1 M € | +18.1% | 1,7 M € | +12.6% | 1,6 M € | +19.2% | 1,3 M € | +16.3% | 1,1 M € | +21.6% | 921,6 k € | +22.6% | 751,4 k € | +50.8% | 498,3 k € | +27.7% | 390,3 k € |
| Total assets | 5,8 M € | +16.9% | 4,9 M € | +34.5% | 3,7 M € | +2.5% | 3,6 M € | +21.8% | 2,9 M € | -11.0% | 3,3 M € | +8.8% | 3 M € | +14.2% | 2,7 M € | +4.5% | 2,5 M € | -5.6% | 2,7 M € | -11.7% | 3 M € | +13.1% | 2,7 M € | +12.2% | 2,4 M € | +3.5% | 2,3 M € | +19.8% | 1,9 M € | +14.5% | 1,7 M € | +24.6% | 1,4 M € | -4.0% | 1,4 M € | +16.6% | 1,2 M € | +10.6% | 1,1 M € |
| Cash | 372,1 k € | -85.0% | 2,5 M € | +112% | 1,2 M € | -20.8% | 1,5 M € | +23.3% | 1,2 M € | -36.2% | 1,9 M € | +26.0% | 1,5 M € | -1.5% | 1,5 M € | +10.7% | 1,4 M € | +346% | 307,4 k € | -73.5% | 1,2 M € | +33.6% | 868,7 k € | +38.4% | 627,8 k € | +33.4% | 470,6 k € | +71.2% | 275 k € | +62.8% | 168,9 k € | +503% | 28 k € | -52.6% | 59,1 k € | -46.1% | 109,6 k € | +229% | 33,3 k € |
| Debts | 484,7 k € | -68.2% | 1,5 M € | +53.2% | 996 k € | -46.9% | 1,9 M € | -20.0% | 2,3 M € | +11.9% | 2,1 M € | +13.8% | 1,8 M € | +28.4% | 1,4 M € | +9.5% | 1,3 M € | -11.2% | 1,5 M € | +183% | 520,9 k € | -17.2% | 629,1 k € | -3.5% | 651,6 k € | -14.9% | 766,1 k € | +21.0% | 633,3 k € | +11.1% | 569,8 k € | +31.5% | 433,4 k € | -34.4% | 660,7 k € | -7.4% | 713,2 k € | +1.1% | 705,2 k € |
| Other | |||||||||||||||||||||||||||||||||||||||
| Workforce | 9,4 ETP | -21.7% | 12,0 ETP | +18.8% | 10,1 ETP | -4.7% | 10,6 ETP | -8.6% | 11,6 ETP | +6.4% | 10,9 ETP | +7.9% | 10,1 ETP | +1.0% | 10,0 ETP | +7.5% | 9,3 ETP | -5.1% | 9,8 ETP | +4.3% | 9,4 ETP | +9.3% | 8,6 ETP | +7.5% | 8,0 ETP | +15.9% | 6,9 ETP | 0.0% | 6,9 ETP | +1.5% | 6,8 ETP | +7.9% | 6,3 ETP | -1.6% | 6,4 ETP | +3.2% | 6,2 ETP | 0.0% | 6,2 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 2 active · 20 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
AstriVax Therapeutics● Active | 0787.990.881 |
AUGUSTINE THERAPEUTICS● Active | 0722.705.230 |
COULTREON BIOPHARMA● Active | 1019.429.814 |
K5 Therapeutics● Active | 0757.718.072 |
Metaptys● Active | 0554.664.311 |
Montis Biosciences● Active | 0730.979.429 |
Perseus Biomics● Active | 0650.946.412 |
ReWind Therapeutics● Active | 0682.626.216 |
| 1040.853.946 | |
Tavira Therapeutics● Active | 0802.591.262 |
VEDRA THERAPEUTICS● Active | 1039.565.628 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 16/06/2026 | 30/06/2025 | 15/06/2024 | 13/06/2023 | 21/06/2022 | 19/05/2021 |
| General meeting | 29/05/2026 | 30/05/2025 | 31/05/2024 | 31/05/2023 | 31/05/2022 | 30/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/05/2026 | 16/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 30/05/2025 | 30/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 31/05/2024 | 15/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 31/05/2023 | 13/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 31/05/2022 | 21/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 30/04/2021 | 19/05/2021 | Dutch | |
| Abridged model | 31/12/2019 | 21/04/2020 | 05/05/2020 | Dutch | |
| Abridged model | 31/12/2018 | 31/05/2019 | 12/06/2019 | Dutch | |
| Abridged model | 31/12/2017 | 24/04/2018 | 29/05/2018 | Dutch | |
| Abridged model | 31/12/2016 | 31/05/2017 | 30/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 31/05/2016 | 09/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 29/05/2015 | 15/06/2015 | Dutch | |
| Abridged model | 31/12/2013 | 31/05/2014 | 17/06/2014 | Dutch | |
| Abridged model | 31/12/2012 | 31/05/2013 | 03/06/2013 | Dutch | |
| Abridged model | 31/12/2011 | 31/05/2012 | 04/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 31/05/2011 | 06/06/2011 | Dutch | |
| Abridged model | 31/12/2009 | 31/05/2010 | 24/06/2010 | Dutch | |
| Abridged model | 31/12/2008 | 30/05/2009 | 25/06/2009 | Dutch | |
| Abridged model | 31/12/2007 | 21/06/2008 | 18/07/2008 | Dutch | |
| Abridged model | 31/12/2006 | 31/05/2007 | 11/06/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 25 M€ and 50 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 2 active · 20 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Capital / shares05/05/2026KAPITAAL - AANDELEN
- Registered office17/11/2025MAATSCHAPPELIJKE ZETEL
- Mandates08/11/2024ONTSLAGEN - BENOEMINGEN
- Mandates28/03/2024ONTSLAGEN - BENOEMINGEN
- Mandates18/07/2023ONTSLAGEN - BENOEMINGEN
- Mandates27/03/2023ONTSLAGEN - BENOEMINGEN
- Capital / shares04/10/2021KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates22/07/2021ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20252,6 M €↓
- 2024Annual accounts 20242,7 M €↑
- 2023Annual accounts 20232,6 M €↑
- 2022Annual accounts 20222,3 M €↑
- 2021Annual accounts 20211,9 M €↑
- 2020Annual accounts 20201,7 M €↑
- 2019Annual accounts 20191,4 M €↑
- 2018Annual accounts 20181 M €↑
- 2017Annual accounts 2017883,8 k €↓
- 2016Annual accounts 2016990,3 k €↑
- 2015Annual accounts 2015611,8 k €↑
- 2014Annual accounts 2014515,5 k €↑
- 2013Annual accounts 2013395,3 k €↓
- 2012Annual accounts 2012399,8 k €↑
- 2011Annual accounts 2011248,8 k €↓
- 2010Annual accounts 2010298,8 k €↑
- 2009Annual accounts 2009170,1 k €↓
- 2008Annual accounts 2008253,2 k €↑
- 2007Annual accounts 2007107,9 k €↑
- 2006Annual accounts 200642,5 k €
- 20/10/1992IncorporationPublic limited company